A (NIH)-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants at the University of Maryland School of Medicine, Baltimore.

In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The findings suggest that the treatment may work as an add-on therapy to standard ...

A new analysis led by surgeons at UCLA Health finds that psychological prehabilitation can significantly enhance recovery ...

Macular degeneration, particularly age-related macular degeneration, is a leading cause of vision loss worldwide.  This ...

Cytokinetics has a strong cash runway but faces risks from its Royalty Pharma deal. Read more on what's ahead for this ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

Surgical removal of enlarged tonsils and adenoids in children with mild sleep-disordered breathing (SDB) appears to ...